INNOVIA Biobank: Charting Uncharted Territories in Regenerative Medicine. In the vast continuum of medical breakthroughs, the world stands poised on the precipice of a transformative era. This epoch is being shaped by the groundbreaking feats of stem cell therapy and regenerative medicine. . INNOVIA Biobank is pioneering such a monumental shift in the MENA region. INNOVIA Biobank, the parent company of BabyCord and several other subsidiaries, is Jordan’s first biobank and a symbol of relentless innovation, dedication, and foresight. Starting out as an umbilical cord blood and tissue storage facility, it grew to become a leading medical and research facility. In 2016, in order to expand prospects for cutting-edge medical applications and treatments utilizing stem cells isolated from umbilical cord blood and tissue in the MENA region, Dr. Maher Sarraf founded BabyCord, a subsidiary of INNOVIA Biobank, in Jordan. This came about after more than 11 years of serving as agents on behalf of a stem cell bank in Boston
